Outside of the clinic, Sara works as the Study Coordinator for an FDA approved randomized controlled trial of MDMA-assisted psychotherapy for PTSD at the University of Connecticut Health Center (UCHC) in the Department of Psychiatry, in Farmington, Connecticut. This is a cutting-edge treatment for people who have not responded to traditional therapies for PTSD. Prior to her move to Connecticut, she worked as a licensed marriage and family therapist at the Behavioral Wellness Clinic in Louisville, Kentucky.
Sara's role in the MDMA-assisted psychotherapy includes screening potential participants, coordinating medical tests, and providing psychotherapy. She has received extensive training in the delivery of MDMA-assisted psychotherapy through the Multidisciplinary Association for Psychedelic Studies (MAPS) with study director Dr. Michael Mithoefer and many other experts on the MAPS team. She is also certified in internal family systems therapy and is familiar with Holotrophic Breathwork. Sara is available to assist people who are working to integrate and resolve experiences involving non-ordinary states of consciousness.
Ching, T. H. W., Williams, M. T., Kisicki, Reed, S. J., & George, J. (2017, November). MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD: MAPS-Sponsored Phase 2 Findings & Cultural Considerations for Phase 3 Trials. Poster session at the 51st Annual Convention of the Association of Behavioral and Cognitive Therapies, San Diego, CA.